Business

Envoy Medical Expands Patent Portfolio with New Issuances in the United States

White Bear Lake, Minnesota--(Newsfile Corp. - July 8, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced the issuance of two new patents, further strengthening its intellectual property portfolio in the United States.The U.S. Patent & Trademark Office has issued two additional patents to Envoy Medical:U.S. Patent No. 12,318,607, on June 3, 2025. The title of the patent is Impl

articleEnvoy Medical, Inc.July 8, 20257/company/envoy-medical-inc/news/envoy-medical-expands-patent-portfolio-120000387
Envoy Medical Expands Patent Portfolio with New Issuances in the United States

About this update from Envoy Medical, Inc.

[{"type":"text","content":"White Bear Lake, Minnesota--(Newsfile Corp. - July 8, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced the issuance of two new patents, further strengthening its intellectual property portfolio in the United States.","length":348,"tagName":"p"},{"type":"text","content":"The U.S. Patent & Trademark Office has issued two additional patents to Envoy Medical:","length":90,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"U.S. Patent No. 12,318,607, on June 3, 2025. The title of the patent is Implantable Cochlear System with Integrated Components and Lead Characterization. Aspects of this patent relate to methods of compensating for variability in a middle ear sensor. Input signals from a middle ear sensor representing received stimulus signals are filtered using analog and digital filters, and the digital filter is adjusted to normalize the frequency response of the digitally filtered signals with respect to the stimulus signals across a plurality of frequencies or frequency ranges.","length":572,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":572,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"U.S. Patent No. 12,318,613, on June 3, 2025. The title of the patent is Implantable Cochlear Implant System with Integrated Signal Analysis Functionality. Aspects of this patent involve using an external device to designate a signal within a fully implantable cochlear implant system for analysis and to receive a representative signal from the cochlear implant system. The external device outputs a representation of the signal for analysis by a user.","length":452,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":452,"olType":false},{"type":"text","content":""We believe these recent patent issuances further demonstrate our team's ability to innovate and push boundaries in hearing health," said Brent Lucas, CEO of Envoy Medical.","length":186,"tagName":"p"},{"type":"text","content":"Envoy Medical's fully implanted technologies are designed to eliminate external components and leverage the natural anatomy of the ear for sound detection, offering a fundamentally different experience from traditio...

More updates from Envoy Medical, Inc.

Envoy Medicalhearing healthAcclaim